You searched for: adalimumaba (Slovenska - Engelska)

1 viala s 40 mg adalimumaba
1 vial containing 40 mg adalimumab

1 viala s 40 mg adalimumaba do
1 vial containing 40 mg adalimumab 1 sterile injection syringe with fixed needle no

predpisal 40 mg adalimumaba vsak teden.
if you have rheumatoid arthritis and you do not receive methotrexate with your trudexa therapy, your doctor may decide to give 40 mg adalimumab every week. t uc

uporaba adalimumaba med nosečnostjo ni priporočljiva.
administration of adalimumab is not recommended during pregnancy.

zato kombinacija adalimumaba in anakinre ni priporočena.
therefore, the combination of adalimumab and anakinra is not recommended.

ena 0,8 ml viala vsebuje 40 mg adalimumaba.
one 0.8 ml vial contains 40 mg adalimumab

1 napolnjena injekcijska brizga s 40 mg adalimumaba do
1 pre-filled syringe containing 40 mg adalimumab 1 alcohol pad no

2 napolnjena injekcijska peresnika s po 40 mg adalimumaba do
2 pre-filled pens, each containing 40 mg adalimumab 2 alcohol pads no

en 0,4ml napolnjen injekcijski peresnik vsebuje 40 mg adalimumaba.
one 0.4 ml pre-filled pen contains 40 mg adalimumab

napolnjena injekcijska brizga s 40 mg adalimumaba 1 alkoholni zloženec
pre-filled syringe containing 40 mg adalimumab 1 alcohol pad

napolnjeni injekcijski brizgi s po 40 mg adalimumaba 2 alkoholna zloženca
pre-filled syringes, each containing 40 mg adalimumab 2 alcohol pads

4 napolnjene injekcijske brizge s po 40 mg adalimumaba 4 alkoholni zloženci
4 pre-filled syringes, each containing 40 mg adalimumab 4 alcohol pads

viala s trudexo je steklena viala, ki vsebuje raztopino adalimumaba.
the trudexa vial is a glass vial containing a solution of adalimumab.

napolnjena injekcijska brizga je steklena brizga, ki vsebuje raztopino adalimumaba.
the trudexa pre-filled syringe is a glass syringe containing a solution of adalimumab.

viala z zdravilom humira je steklena viala, ki vsebuje raztopino adalimumaba.
the humira vial is a glass vial containing a solution of adalimumab.

Če je predviden kirurški poseg, je treba upoštevati dolgi razpolovni čas adalimumaba.
the long half-life of adalimumab should be taken into consideration if a surgical procedure is planned.

zato kombinacija adalimumaba in anakinre ni priporočena (glejte poglavje 4.5).
therefore, the combination of adalimumab and anakinra is not recommended. (see section 4.5).

predkliničnih podatkov o poporodni toksičnosti adalimumaba ni (glejte poglavje 5.3).
preclinical data on postnatal toxicity of adalimumab are not available (see section 5.3).